ChEMBL Group, EMBL-EBI, Wellcome Trust Genome Campus, CB10 1SD Hinxton, United Kingdom.
Computational Chemistry, Janssen Research & Development , Turnhoutseweg 30, B-2340 Beerse, Belgium.
J Chem Inf Model. 2017 Dec 26;57(12):2976-2985. doi: 10.1021/acs.jcim.7b00338. Epub 2017 Dec 12.
Proteochemometric modeling (PCM) is a computational approach that can be considered an extension of quantitative structure-activity relationship (QSAR) modeling, where a single model incorporates information for a family of targets and all the associated ligands instead of modeling activity versus one target. This is especially useful for situations where bioactivity data exists for similar proteins but is scarce for the protein of interest. Here we demonstrate the application of PCM to identify allosteric modulators of metabotropic glutamate (mGlu) receptors. Given our long-running interest in modulating mGlu receptor function we compiled a matrix of compound-target bioactivity data. Some members of the mGlu family are well explored both internally and in the public domain, while there are much fewer examples of ligands for other targets such as the mGlu receptor. Using a PCM approach mGlu receptor hits were found. In comparison to conventional single target modeling the identified hits were more diverse, had a better confirmation rate, and provide starting points for further exploration. We conclude that the robust structure-activity relationship from well explored target family members translated to better quality hits for PCM compared to virtual screening (VS) based on a single target.
基于配体的药效团模型(proteochemometric modeling,PCM)是一种计算方法,可以被视为定量构效关系(QSAR)模型的扩展,其中单一模型整合了一系列靶标和所有相关配体的信息,而不是针对一个靶标进行活性建模。当针对感兴趣的蛋白的生物活性数据稀缺,但存在类似蛋白的大量生物活性数据时,这种方法特别有用。在这里,我们展示了基于配体的药效团模型(PCM)在鉴定代谢型谷氨酸(mGlu)受体变构调节剂中的应用。鉴于我们长期以来对调节 mGlu 受体功能的兴趣,我们编制了一个化合物-靶标生物活性数据矩阵。mGlu 家族的一些成员在内部和公共领域都得到了很好的研究,而其他靶标(如 mGlu 受体)的配体则要少得多。使用 PCM 方法发现了 mGlu 受体的命中化合物。与传统的单一靶标建模相比,鉴定出的命中化合物更加多样化,确认率更高,为进一步探索提供了起点。我们得出结论,与基于单一靶标的虚拟筛选(VS)相比,来自探索充分的靶标家族成员的稳健构效关系可以为 PCM 提供更高质量的命中化合物。